MRKR Marker Therapeutics, Inc. - Common Stock
MRKR Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
MRKR Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
MRKR Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
- Acquisto forte 2 22,2%
- Compra 6 66,7%
- Mantieni 1 11,1%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
3 analisti · 2026-08-19Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 31 Marzo 2026 | $-0.16 | $-0.19 | 0.03% |
| 31 Dicembre 2025 | $-0.09 | $-0.20 | 0.11% |
| 30 Settembre 2025 | $-0.12 | $-0.46 | 0.34% |
| 30 Giugno 2025 | $-0.29 | $-0.42 | 0.13% |
| 31 Marzo 2025 | $-0.36 | $-0.50 | 0.14% |
| 31 Dicembre 2024 | $-0.42 | $-0.22 | -0.20% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| MRKR | $25M | -1.9 | -46.2% | -343.0% | -89.1% | — |
| NEUP | $14M | -30.9 | — | -2.4% | -2.3% | — |
| CELU | $32M | -0.3 | -51.0% | -345.4% | 288.6% | — |
| CLRB | — | -0.4 | — | — | — | — |
| HOWL | $31M | -0.5 | — | — | -183.6% | — |
| SKYE | $25M | -0.5 | — | — | -175.6% | — |
| KALA | $15M | -0.2 | — | — | -1423.8% | — |
| CYCN | — | -1.1 | 3.7% | — | — | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $7M | $3M | $4M | $1M | $500.0K | $213.2K | $206.0K | $183.1K | |
| R&D Expense | $12M | $13M | $10M | $12M | $28M | $19M | $13M | $8M | $5M | |
| SG&A Expense | $4M | $4M | $7M | $11M | $13M | $10M | $10M | $24M | $6M | |
| Operating Expenses | $16M | $18M | $18M | $23M | $41M | $29M | $23M | $148M | $12M | |
| Operating Income | $-13M | $-11M | $-15M | $-20M | $-39M | $-29M | $-23M | $-148M | $-11M | |
| Interest Income | $594.2K | $437.0K | $539.2K | $248.1K | $5.7K | $148.7K | $1M | $253.7K | $0 | |
| Pretax Income | $-12M | $-11M | $-14M | $-20M | · | · | · | · | · | |
| Income Tax | $-15.2K | $50.0K | $3.7K | · | · | · | · | $0 | $0 | |
| Net Income | $-12M | $-11M | $-8M | $-30M | $-42M | $-29M | $-21M | $-148M | $-11M | |
| EPS (Basic) | $-0.79 | $-1.19 | $-0.94 | $-3.58 | $-5.47 | $-0.61 | · | · | $-1.16 | |
| EPS (Diluted) | $-0.79 | $-1.19 | $-0.94 | $-3.58 | $-5.47 | $-0.61 | · | · | $-1.16 | |
| Shares (Basic) | 15,310,308 | 8,980,207 | 8,809,382 | 8,351,003 | 7,650,567 | 47,039,862 | 45,587,734 | 19,091,926 | 9,453,483 | |
| Shares (Diluted) | 15,310,308 | 8,980,207 | 8,809,382 | 8,351,003 | 7,650,567 | 47,039,862 | · | · | 9,453,483 | |
| EBITDA | $-13M | $-11M | $-15M | $-27M | $-37M | $-28M | $-22M | $-148M | $-12M |
Stato Patrimoniale 20
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $19M | $15M | $12M | $42M | $21M | $44M | $62M | $5M | |
| Prepaid Expense | $658.8K | $483.7K | $988.1K | $2M | $2M | $2M | $2M | $141.7K | $51.1K | |
| Other Current Assets | · | $2.0K | · | · | · | · | · | · | · | |
| Current Assets | $19M | $22M | $17M | $17M | $46M | $24M | $45M | $62M | $5M | |
| PP&E (Net) | · | · | · | $12M | $12M | $10M | $418.0K | $147.7K | $0 | |
| PP&E (Gross) | · | · | · | $18M | $13M | $4M | $523.0K | $148.0K | $0 | |
| Accum. Depreciation | · | · | · | $5M | $3M | $591.0K | $105.0K | $0 | $0 | |
| Total Assets | $19M | $22M | $17M | $34M | $68M | $46M | $46M | $62M | $5M | |
| Accounts Payable | $793.7K | $1M | $961.0K | $1M | $5M | $3M | $993.0K | $2M | $1M | |
| Short-term Debt | · | · | · | · | · | · | · | · | $5.0K | |
| Current Liabilities | $2M | $3M | $3M | $8M | $13M | $6M | $2M | $3M | $2M | |
| Capital Leases | · | · | · | $7M | $11M | $12M | $280.2K | $0 | · | |
| Total Liabilities | $2M | $3M | $3M | $15M | $24M | $18M | $2M | $3M | $2M | |
| Total Debt | · | · | · | · | · | · | · | · | $5.0K | |
| Common Stock | $16.7K | $10.7K | $8.9K | $8.4K | $8.3K | $50.7K | $45.7K | $45.4K | $10.6K | |
| Paid-in Capital | $476M | $466M | $450M | $448M | $442M | $384M | $372M | $365M | $161M | |
| Retained Earnings | $-459M | $-447M | $-436M | $-428M | $-398M | $-356M | $-328M | $-306M | $-157M | |
| Stockholders' Equity | $17M | $19M | $14M | $20M | $44M | $27M | $44M | $59M | $4M | |
| Liabilities + Equity | $19M | $22M | $17M | $34M | $68M | $46M | $46M | $62M | $5M | |
| Shares Outstanding | 16,700,000 | 10,700,000 | 8,900,000 | 8,400,000 | 8,300,000 | 50,700,000 | 45,700,000 | 45,400,000 | 10,600,000 |
Flusso di cassa 13
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $3M | $2M | $485.6K | $105.1K | · | · | |
| Stock-based Comp | $537.5K | $245.9K | $858.3K | $3M | $6M | $5M | $5M | $16M | $3M | |
| Other Non-cash | · | · | · | $-5M | $6M | $4M | $-2M | · | · | |
| Operating Cash Flow | $-12M | $-11M | $-16M | $-27M | $-27M | $-20M | $-18M | $-14M | $-8M | |
| CapEx | · | · | · | · | · | · | $375.0K | $147.7K | $0 | |
| Investing Cash Flow | · | · | $19M | $-5M | $-3M | $-9M | $-375.0K | $-147.7K | $0 | |
| Stock Issued | $10M | $15M | $1M | $202.1K | $53M | $6M | $0 | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | $71.7K | $310.5K | |
| Net Stock Activity | $10M | · | $1M | $202.1K | $53M | $6M | · | $-71.7K | $-310.5K | |
| Financing Cash Flow | $10M | $15M | $1M | $202.1K | $53M | $7M | $816.5K | $71M | $6M | |
| Net Change in Cash | · | · | · | $12M | $44M | · | · | · | · | |
| Taxes Paid | $42.0K | $72.2K | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | $-19M | $-15M | · |
Redditività 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -363.4% | -168.7% | -440.4% | -332.2% | · | -6188.2% | -10567.3% | -71930.1% | · | |
| Net Margin | -343.0% | -162.8% | -248.8% | -332.1% | · | -6149.7% | -10050.9% | -71826.3% | · | |
| Pretax Margin | -343.4% | -162.1% | -424.1% | · | · | · | · | · | · | |
| EBITDA Margin | -363.4% | -168.7% | -440.4% | -301.3% | · | -6084.2% | -10518.0% | -71930.1% | · | |
| ROA | -59.2% | -54.8% | -32.0% | -58.4% | -73.6% | -62.4% | -39.5% | -439.5% | -167.6% | |
| ROE | -89.1% | -82.5% | -53.6% | -141.8% | -87.0% | -99.1% | -46.6% | -492.9% | -223.2% | |
| ROIC | -76.6% | -60.2% | -103.8% | · | · | · | · | · | · |
Liquidità e Solvibilità 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 6.4 | 5.6 | 2.1 | 3.6 | 3.8 | 22.8 | 22.1 | 3.4 | |
| Quick Ratio | 7.1 | 5.5 | 4.9 | 1.5 | 3.3 | 3.3 | 22.0 | 22.0 | 3.4 | |
| Debt / Equity | · | · | · | · | · | · | · | · | 0.0 |
Efficienza 1
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.3 | 0.1 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | · |
Tassi di Crescita 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -46.2% | 99.1% | -5.8% | 183.0% | 148.3% | · | · | · | · | |
| Revenue CAGR 3Y | 0.31% | 74.4% | 87.8% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 48.0% | · | · | · | · | · | · | · | · |
Valutazione (TTM) 13
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $7M | $3M | $4M | $1M | $500.0K | $213.2K | $206.0K | $183.1K | |
| Net Income TTM | $-12M | $-11M | $-8M | $-30M | $-42M | $-29M | $-21M | $-148M | $-11M | |
| Market Cap | $25M | $33M | $49M | $23M | $789M | $735M | $1.32B | $2.52B | $416M | |
| Enterprise Value | · | · | · | · | · | · | · | · | $410M | |
| P/E | -1.9 | -2.6 | -5.9 | -0.8 | -1.7 | -23.8 | · | · | -33.8 | |
| P/S | 7.0 | 5.0 | 14.8 | 6.5 | 635.8 | 1470.3 | 6173.5 | 12231.9 | 2269.8 | |
| P/B | 1.5 | 1.8 | 3.5 | 1.2 | 17.9 | 26.9 | 29.9 | 42.5 | 113.6 | |
| P / Tangible Book | 1.5 | 1.8 | 3.5 | 1.2 | 17.9 | 26.9 | · | · | · | |
| P / Cash Flow | -2.1 | -3.0 | -3.0 | -0.8 | -28.9 | -39.0 | -72.0 | -174.0 | -49.2 | |
| P / FCF | · | · | · | · | · | · | -70.5 | -172.3 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | -35.2 | |
| EV / Revenue | · | · | · | · | · | · | · | · | 2241.8 | |
| Earnings Yield | -53.0% | -38.3% | -17.1% | -132.6% | -57.6% | -4.2% | · | · | -3.0% |
Conto Economico 12
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $751.7K | $1M | $1M | $861.2K | $349.1K | $2M | $2M | $1M | $1M | $1M | $257.6K | $762.7K | $1M | $759.1K | $999.6K | |
| R&D Expense | $1M | $3M | $2M | $2M | $4M | $3M | $5M | $3M | $2M | $3M | $3M | $2M | $2M | $3M | $-2M | $4M | |
| SG&A Expense | $1M | $1M | $846.6K | $1M | $945.2K | $1M | $1M | $854.7K | $1M | $1M | $1M | $1M | $3M | $2M | $1M | $3M | |
| Operating Expenses | $3M | $4M | $3M | $3M | $5M | $5M | $6M | $4M | $3M | $4M | $4M | $3M | $5M | $6M | $-339.6K | $7M | |
| Operating Income | $-3M | $-4M | $-2M | $-2M | $-5M | $-5M | $-4M | $-2M | $-2M | $-3M | $-3M | $-3M | $-4M | $-4M | $1M | $-6M | |
| Interest Income | $112.6K | $132.9K | $165.6K | $138.1K | $128.0K | $162.5K | $73.7K | $91.7K | $115.4K | $156.2K | $201.3K | $218.1K | $35.1K | $84.7K | $109.4K | $99.8K | |
| Net Income | $-2M | $-3M | $-2M | $-2M | $-4M | $-4M | $-4M | $-2M | $-2M | $-2M | $-3M | $-3M | $3M | $-5M | $-4M | $-7M | |
| EPS (Basic) | $-0.09 | $-0.16 | $0.02 | $-0.12 | $-0.29 | $-0.40 | $-0.41 | $-0.26 | $-0.25 | $-0.27 | $-0.32 | $-0.34 | $0.29 | $-0.57 | $-0.45 | $-0.83 | |
| EPS (Diluted) | $-0.09 | $-0.16 | $0.02 | $-0.12 | $-0.29 | $-0.40 | $-0.41 | $-0.26 | $-0.25 | $-0.27 | $-0.32 | $-0.34 | $0.29 | $-0.57 | $-0.45 | $-0.83 | |
| Shares (Basic) | 19,314,742 | 19,314,742 | -26,509,959 | 16,757,678 | 13,956,562 | 11,106,027 | -17,763,158 | 8,923,170 | 8,918,233 | 8,901,962 | -17,536,486 | 8,825,881 | 8,798,956 | 8,721,031 | -16,678,887 | 8,359,920 | |
| Shares (Diluted) | 19,314,742 | 19,314,742 | -26,509,959 | 16,757,678 | 13,956,562 | 11,106,027 | -17,763,158 | 8,923,170 | 8,918,233 | 8,901,962 | -17,536,486 | 8,825,881 | 8,798,956 | 8,721,031 | -16,678,887 | 8,359,920 | |
| EBITDA | $-3M | $-4M | · | $-2M | $-4M | $-5M | · | $-2M | $-2M | $-3M | · | $-3M | $-4M | $-4M | · | $-7M |
Stato Patrimoniale 18
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $15M | $16M | $18M | $10M | $14M | $19M | $9M | $8M | $11M | $15M | $17M | $18M | $6M | $12M | $18M | |
| Prepaid Expense | $1M | $418.1K | · | · | · | $841.3K | · | $1M | $1M | $917.0K | $988.1K | $2M | $2M | $2M | $2M | $3M | |
| Other Current Assets | $7.2K | $13.2K | · | · | · | · | $2.0K | · | · | · | · | · | · | · | · | · | |
| Current Assets | $15M | $17M | $19M | $22M | $15M | $17M | $22M | $11M | $12M | $14M | $17M | $19M | $22M | $11M | $17M | $22M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | $12M | · | $13M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $18M | · | $18M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $6M | · | $5M | |
| Total Assets | $15M | $17M | $19M | $22M | $15M | $17M | $22M | $11M | $12M | $14M | $17M | $19M | $22M | $28M | $34M | $41M | |
| Accounts Payable | $585.0K | $2M | $793.7K | $951.0K | $2M | $1M | $1M | $2M | $1M | $1M | $961.0K | $1M | $1M | $3M | $1M | $2M | |
| Current Liabilities | $2M | $4M | $2M | $3M | $4M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $3M | $5M | $8M | $11M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | · | · | $7M | · | $7M | |
| Total Liabilities | $2M | $4M | $2M | $3M | $4M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $3M | $12M | $15M | $19M | |
| Common Stock | $16.7K | $16.7K | $16.7K | $16.7K | $11.3K | $11.2K | $10.7K | $8.9K | $8.9K | $8.9K | $8.9K | $8.9K | $8.8K | $8.8K | $8.4K | $83.6K | |
| Paid-in Capital | $476M | $476M | $476M | $476M | $466M | $466M | $466M | $451M | $451M | $450M | $450M | $450M | $450M | $449M | $448M | $447M | |
| Retained Earnings | $-464M | $-462M | $-459M | $-457M | $-455M | $-451M | $-447M | $-443M | $-441M | $-439M | $-436M | $-433M | $-431M | $-433M | $-428M | $-424M | |
| Stockholders' Equity | $12M | $14M | $17M | $18M | $10M | $14M | $19M | $7M | $10M | $12M | $14M | $17M | $19M | $16M | $20M | $23M | |
| Liabilities + Equity | $15M | $17M | $19M | $22M | $15M | $17M | $22M | $11M | $12M | $14M | $17M | $19M | $22M | $28M | $34M | $41M | |
| Shares Outstanding | 16,700,000 | 16,700,000 | 16,700,000 | 16,700,000 | 11,300,000 | 11,200,000 | 10,700,000 | 8,900,000 | 8,900,000 | 8,900,000 | 8,900,000 | 8,800,000 | 8,800,000 | 8,800,000 | 8,400,000 | 83,600,000 |
Flusso di cassa 8
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | · | · | $818.2K | · | $819.9K | |
| Stock-based Comp | $195.7K | $178.4K | $111.1K | $33.3K | $14.0K | $379.1K | $50.5K | $53.3K | $62.6K | $79.4K | $143.4K | $175.0K | $-120.1K | $659.9K | $382.9K | $-210.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-4M | $-1M | $-2M | $-3M | $-2M | $-5M | $-5M | $1M | $-4M | $-4M | $-2M | $-1M | $-7M | $-6M | $-6M | $-8M | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $19M | $-112.6K | $-127.3K | $-99.4K | |
| Stock Issued | · | · | $0 | · | · | · | $15M | $0 | · | · | · | $394.7K | $0 | $620.0K | $138.6K | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $620.0K | · | · | |
| Financing Cash Flow | · | · | $0 | $10M | $100 | $505 | $15M | $1.7K | $44.6K | $49.1K | $5.1K | $479.3K | $736 | $620.0K | $138.6K | $0 |
Redditività 5
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -541.8% | · | -173.3% | -494.8% | -1320.1% | · | -124.6% | -197.4% | -204.9% | · | -1242.2% | -542.1% | -106.7% | · | -177.7% | |
| Net Margin | · | -422.9% | · | -162.1% | -466.3% | -1273.6% | · | -119.8% | -187.5% | -192.3% | · | -1157.6% | 329.9% | -104.9% | · | -175.2% | |
| EBITDA Margin | · | -541.8% | · | -173.3% | -494.8% | -1320.1% | · | -124.6% | -197.4% | -204.9% | · | -1242.2% | -542.1% | -89.4% | · | -177.7% | |
| ROA | -12.4% | -18.5% | · | -12.2% | -30.4% | -28.6% | · | -15.2% | -13.0% | -11.4% | · | -9.8% | 6.8% | -12.0% | · | -12.2% | |
| ROE | -16.1% | -22.5% | · | -15.5% | -39.8% | -33.8% | · | -19.1% | -15.3% | -17.3% | · | -15.2% | 10.7% | -19.2% | · | -18.5% |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.0 | 4.8 | · | 6.5 | 3.5 | 6.8 | · | 3.2 | 5.9 | 6.1 | · | 7.0 | 7.5 | 2.1 | · | 2.0 | |
| Quick Ratio | 4.7 | 4.1 | · | 5.3 | 2.4 | 5.5 | · | 2.6 | 4.0 | 4.9 | · | 6.3 | 6.2 | 1.2 | · | 1.6 |
Efficienza 1
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.1 | · | 0.1 |
Valutazione (TTM) 9
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $3M | · | $4M | $4M | $5M | · | $5M | $3M | $3M | · | $3M | $4M | $4M | · | · | |
| Net Income TTM | $-11M | $-14M | · | $-13M | $-13M | $-11M | · | $-10M | $-5M | $-8M | · | $-12M | $-19M | $-31M | · | $-39M | |
| Market Cap | $25M | $22M | · | $15M | $17M | $14M | · | $25M | $48M | $38M | · | $40M | $27M | $6M | · | $309M | |
| P/E | -2.2 | -1.3 | · | -0.8 | -1.3 | -1.0 | · | -2.5 | -9.5 | -4.8 | · | -3.1 | -1.4 | -0.2 | · | -1.1 | |
| P/S | 7.7 | 6.8 | · | 3.4 | 4.0 | 2.9 | · | 5.5 | 14.1 | 10.9 | · | 12.3 | 7.2 | 1.6 | · | · | |
| P/B | 2.0 | 1.6 | · | 0.8 | 1.6 | 1.0 | · | 3.4 | 5.0 | 3.2 | · | 2.4 | 1.4 | 0.4 | · | 13.7 | |
| P / Tangible Book | 2.0 | 1.6 | · | 0.8 | 1.6 | 1.0 | · | 3.4 | 5.0 | 3.2 | · | 2.4 | 1.4 | 0.4 | · | 13.7 | |
| P / Cash Flow | · | -15.5 | · | · | · | -2.5 | · | · | · | -10.0 | · | · | · | -1.1 | · | · | |
| Earnings Yield | -44.9% | -74.6% | · | -120.2% | -78.4% | -95.9% | · | -39.7% | -10.5% | -20.7% | · | -31.9% | -71.6% | -521.1% | · | -88.6% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $4M | $7M | $3M | $4M | $1M |
| Margine Operativo % | -363.4% | -168.7% | -440.4% | -332.2% | — |
| Utile netto | $-12M | $-11M | $-8M | $-30M | $-42M |
| EPS Diluito | $-0.79 | $-1.19 | $-0.94 | $-3.58 | $-5.47 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 8.4 | 6.4 | 5.6 | 2.1 | 3.6 |
| Quick Ratio | 7.1 | 5.5 | 4.9 | 1.5 | 3.3 |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 36 filer · $5.9M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 7 (+3 vs trimestre precedente) | 4 (-3 vs trimestre precedente) | 6 (-1 vs trimestre precedente) | 6 (-1 vs trimestre precedente) | +641K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| NEA Management Company, LLC | $2.389.747 | 1.625.678 | 40,83% | Azioni |
| Blue Owl Capital Holdings LP | $814.748 | 554.250 | 13,92% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $626.468 | 426.169 | 10,70% | Azioni |
| Aisling Capital Management LP | $478.293 | 325.370 | 8,17% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $366.652 | 249.423 | 6,26% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $158.786 | 107.998 | 2,71% | Azioni |
| OSAIC HOLDINGS, INC. | $148.241 | 100.847 | 2,53% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $128.285 | 87.269 | 2,19% | Azioni |
| LPL Financial LLC | $122.226 | 83.147 | 2,09% | Azioni |
| VANGUARD GROUP INC | $109.618 | 73.569 | 1,87% | Azioni |
| Concurrent Investment Advisors, LLC | $99.906 | 67.963 | 1,71% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $88.495 | 60.201 | 1,51% | Azioni |
| XTX Topco Ltd | $66.675 | 45.357 | 1,14% | Azioni |
| NORTHERN TRUST CORP | $50.905 | 34.629 | 0,87% | Azioni |
| CITADEL ADVISORS LLC | $47.800 | 32.517 | 0,82% | Azioni |
| STATE STREET CORP | $30.794 | 20.948 | 0,53% | Azioni |
| Invst, LLC | $26.460 | 18.000 | 0,45% | Azioni |
| Creative Planning | $25.449 | 17.312 | 0,43% | Azioni |
| Ashton Thomas Private Wealth, LLC | $24.108 | 16.400 | 0,41% | Azioni |
| FIFTH THIRD BANCORP | $14.700 | 10.000 | 0,25% | Azioni |
| JANE STREET GROUP, LLC | $13.936 | 9.480 | 0,24% | Azioni |
| UBS Group AG | $11.981 | 8.150 | 0,20% | Azioni |
| Vanguard Global Advisers, LLC | $3.693 | 2.512 | 0,06% | Azioni |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $2.900 | 2.000 | 0,05% | Azioni |
| Tower Research Capital LLC (TRC) | $1.191 | 810 | 0,02% | Azioni |
| WELLS FARGO & COMPANY/MN | $341 | 232 | 0,01% | Azioni |
| SIGNATUREFD, LLC | $335 | 228 | 0,01% | Azioni |
| SBI Securities Co., Ltd. | $298 | 203 | 0,01% | Azioni |
| GROUP ONE TRADING LLC | $262 | 178 | 0,00% | Azioni |
| Hilltop National Bank | $107 | 73 | 0,00% | Azioni |
| BARCLAYS PLC | $93 | 63 | 0,00% | Azioni |
| JPMORGAN CHASE & CO | $34 | 23 | 0,00% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $34 | 23 | 0,00% | Azioni |
| Virtu Financial LLC | $17 | 11.574 | 0,00% | Azioni |
| Caitong International Asset Management Co., Ltd | $13 | 9 | 0,00% | Azioni |
| MORGAN STANLEY | $1 | 1 | 0,00% | Azioni |
Insider aziendali 36 insider · 14 dirigenti · 17 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Juan Vera | President and CEO | 12 Febbraio 2025 A | 2.671.845 | 0 | 0 | $0 |
| Peter L. Hoang | President and CEO | 24 Marzo 2022 F | 483.286 | 0 | 0 | $0 |
| Ronald L Handford | President/CEO | 16 Dicembre 2003 A | — | 0 | 0 | $0 |
| Anthony H. Kim | Chief Financial Officer | 24 Marzo 2022 F | 114.436 | 0 | 0 | $0 |
| Tracy A Moore | Chief Financial Officer | 14 Ottobre 2009 A | 500.000 | 0 | 0 | $0 |
| John N Bonfiglio | President and COO | 09 Marzo 2017 A | 26.054 | 0 | 0 | $0 |
| Denis Corin | President | 17 Febbraio 2012 J | 2.394.535 | 0 | 0 | $0 |
| Anna Szymanska | Vice President, Quality | 27 Febbraio 2023 A | — | 0 | 0 | $0 |
| Nadia Agopyan | SVP, Regulatory Affairs | 27 Febbraio 2023 A | — | 0 | 0 | $0 |
| Mythili Koneru | Chief Medical Officer | 27 Febbraio 2023 A | — | 0 | 0 | $0 |
| Tsvetelina P Hoang | VP, Research and Development | 27 Febbraio 2023 A | — | 0 | 0 | $0 |
| Michael Loiacono | Chief Accounting Officer | 27 Febbraio 2023 A | — | 0 | 0 | $0 |
| Gerald Garrett | Vice President, Clinical Ops. | 17 Febbraio 2022 A | — | 0 | 0 | $0 |
| Wilfred Jefferies | Chief Scientist Officer | 16 Dicembre 2003 A | — | 0 | 0 | $0 |
| Steve Elms | Direttore | 17 Novembre 2025 A | 325.370 | 0 | 0 | $0 |
| Katharine Knobil | Direttore | 12 Febbraio 2025 A | — | 0 | 0 | $0 |
| John Robert Wilson | Direttore | 06 Giugno 2023 A | 7.812.008 | 0 | 0 | $0 |
| David Laskow-Pooley | Direttore | 24 Maggio 2022 A | 55.223 | 0 | 0 | $0 |
| Frederick Gerald Wasserman | Direttore | 08 Giugno 2021 A | 65.223 | 0 | 0 | $0 |
| Sherry Grisewood | Direttore | 16 Ottobre 2018 A | 19.582 | 0 | 0 | $0 |
| Mark Reddish | Direttore | 16 Ottobre 2018 A | 36.110 | 0 | 0 | $0 |
| Joshua Silverman | Direttore | 16 Ottobre 2018 A | 17.221 | 0 | 0 | $0 |
| Glynn Wilson | Direttore | 09 Ottobre 2018 M | 181.776 | 0 | 0 | $0 |
| Alan P Lindsay | Direttore | 11 Marzo 2009 J | — | 0 | 0 | $0 |
| Carmen Chang | Proprietario del 10% | 16 Marzo 2021 P | 10.714.285 | 0 | 0 | $0 |
| Mohamad Makhzoumi | Proprietario del 10% | 16 Marzo 2021 P | 10.714.285 | 0 | 0 | $0 |
| Ali Behbahani | Proprietario del 10% | 16 Marzo 2021 P | 10.714.285 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | Proprietario del 10% | 16 Marzo 2021 P | 10.714.285 | 0 | 0 | $0 |
| Peter W. Sonsini | Proprietario del 10% | 16 Marzo 2021 P | 10.714.285 | 0 | 0 | $0 |
| Paul Walker | Proprietario del 10% | 16 Marzo 2021 P | 10.714.285 | 0 | 0 | $0 |
| Forest Baskett | Proprietario del 10% | 16 Marzo 2021 P | 10.714.285 | 0 | 0 | $0 |
| Scott D. Sandell | Proprietario del 10% | 16 Marzo 2021 P | 10.714.285 | 0 | 0 | $0 |
| Joshua Makower | Proprietario del 10% | 16 Marzo 2021 P | 10.714.285 | 0 | 0 | $0 |
| Norman David Eansor | — | 17 Novembre 2025 A | 7.142 | 0 | 0 | $0 |
| Grant R Atkins | — | 16 Dicembre 2003 A | — | 0 | 0 | $0 |
| GENEMAX CORP | — | 16 Dicembre 2003 A | — | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 29 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell, Paul Walker ×6 depositi | 17 Novembre 2025 | 9,90% | Modifica | Investimento passivo | SEC |
| John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017 ×2 depositi | 20 Agosto 2025 | 4,96% | Modifica | — | SEC |
| Aisling Capital IV, LP, Aisling Capital Partners IV, LP, Aisling Capital Partners IV LLC, Steve Elms, Andrew Schiff | 03 Marzo 2023 | — | Deposito iniziale | — | SEC |
| Ann Leen ×2 depositi | 24 Marzo 2021 | — | Deposito iniziale | — | SEC |
| EASTERN CAPITAL LIMITED, PORTFOLIO SERVICES LTD., KENNETH B. DART ×14 depositi | 15 Marzo 2021 | — | Deposito iniziale | — | SEC |
| Juan Vera | 14 Febbraio 2019 | — | Deposito iniziale | — | SEC |
| John Robert Wilson | 14 Febbraio 2019 | — | Deposito iniziale | — | SEC |
| OR | 19 Ottobre 2018 | — | Deposito iniziale | — | SEC |
| Iroquois Master Fund Ltd., Iroquois Capital Management, LLC, Richard Abbe, Kimberly Page | 04 Aprile 2018 | — | Deposito iniziale | Investimento passivo | SEC |
| Sailesh C Barchha (2) | 27 Febbraio 2013 | — | Deposito iniziale | — | SEC |
| Michael Gardner | 07 Gennaio 2013 | — | Deposito iniziale | — | SEC |
| WILFRED A. JEFFERIES | 20 Luglio 2007 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 03 Ottobre 2002 | — | Deposito iniziale | M&A / vendita | SEC |
| Persona segnalante non divulgata | 20 Agosto 2002 | — | Deposito iniziale | M&A / vendita | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata | 26 Luglio 2002 | — | Deposito iniziale | M&A / vendita | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 2 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.